INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹0.15 Cr | ₹-19 Cr | ₹741 Cr | ₹814 Cr | ₹840 Cr |
What is the latest Total Non-Current Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹0.15 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹741 Cr |
| Mar2022 | ₹814 Cr |
| Mar2021 | ₹840 Cr |
How is Total Non-Current Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.15 Cr | Positive | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹741 Cr | -8.90 | |
| Mar2022 | ₹814 Cr | -3.16 | |
| Mar2021 | ₹840 Cr | - | |
Compare Total Non-Current Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹2,865.3 Cr | 5.1% | 46.1% | 225.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 5.1% |
46.1% |
225.1% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses